Advances in Understanding of Metabolism of B-Cell Lymphoma: Implications for Therapy
There have been significant recent advances in the understanding of the role of metabolism in normal and malignant B-cell biology. Previous research has focused on the role of MYC and mammalian target of rapamycin (mTOR) and how these interact with B-cell receptor signaling and hypoxia to regulate g...
Main Authors: | Katarina Kluckova, Annalisa D’Avola, John Charles Riches |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-11-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/14/22/5552 |
Similar Items
-
Potential Mechanisms Connecting Purine Metabolism and Cancer Therapy
by: Jie Yin, et al.
Published: (2018-07-01) -
Adipocyte-specific DKO of Lkb1 and mTOR protects mice against HFD-induced obesity, but results in insulin resistance
by: Yan Xiong, et al.
Published: (2018-01-01) -
Rheb and mammalian target of rapamycin in mitochondrial homoeostasis
by: Marlous J. Groenewoud, et al.
Published: (2013-01-01) -
Metabolic Reprogramming of Non-Hodgkin's B-Cell Lymphomas and Potential Therapeutic Strategies
by: Jean-Ehrland Ricci, et al.
Published: (2018-12-01) -
Spotlight on New Therapeutic Opportunities for MYC-Driven Cancers
by: D'Avola A, et al.
Published: (2023-06-01)